Biomarkers along the continuum of care in lung cancer

Blood-based biomarkers are valuable diagnostic tools for the management of lung cancer patients. They support not only differential diagnosis and histological subtyping, but are also applied for estimation of prognosis, stratification for specific therapies, monitoring of therapy response, surveilla...

Full description

Saved in:

Bibliographic Details
Published in:	Scandinavian journal of clinical & laboratory investigation. Supplement Vol. 76; no. 45; pp. S40 - S45
Main Author:	Holdenrieder, Stefan
Format:	Journal Article
Language:	English
Published:	Norway Taylor & Francis 13.07.2016
Subjects:	Antigens, Neoplasm - blood Antigens, Neoplasm - genetics Antineoplastic Agents - therapeutic use Biomarker Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Carcinoembryonic Antigen - blood Carcinoembryonic Antigen - genetics diagnosis DNA, Neoplasm - blood DNA, Neoplasm - genetics Early Diagnosis Gene Expression Regulation, Neoplastic Humans Keratin-19 - blood Keratin-19 - genetics liquid profiling lung cancer Lung Neoplasms - diagnosis Lung Neoplasms - drug therapy Lung Neoplasms - genetics Lung Neoplasms - pathology Peptide Fragments - blood Peptide Fragments - genetics personalized medicine Phosphopyruvate Hydratase - blood Phosphopyruvate Hydratase - genetics Prognosis Recombinant Proteins - blood Recombinant Proteins - genetics Serpins - blood Serpins - genetics serum Transcriptome Treatment Outcome lung cancer liquid profiling diagnosis Biomarker serum personalized medicine
ISSN:	0036-5513, 2166-1030, 1502-7686, 2166-1030
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!